These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 39079657)
1. Spiky tubular nanoparticles with low protein corona can realize efficient and non-destructive penetration through endothelial barrier. Huang Y; Ye D; Liu X; Chen H; Luo X; Huang B; Zhou N; Wang H; Zou Q; Fang S; Wang S; Wu L J Control Release; 2024 Oct; 374():1-14. PubMed ID: 39079657 [TBL] [Abstract][Full Text] [Related]
2. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Lee YK; Choi EJ; Webster TJ; Kim SH; Khang D Int J Nanomedicine; 2015; 10():97-113. PubMed ID: 25565807 [TBL] [Abstract][Full Text] [Related]
3. Nanoparticles Penetrate into the Multicellular Spheroid-on-Chip: Effect of Surface Charge, Protein Corona, and Exterior Flow. Huang K; Boerhan R; Liu C; Jiang G Mol Pharm; 2017 Dec; 14(12):4618-4627. PubMed ID: 29096441 [TBL] [Abstract][Full Text] [Related]
4. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications. Moraru C; Mincea M; Menghiu G; Ostafe V Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296 [TBL] [Abstract][Full Text] [Related]
5. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection. Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454 [TBL] [Abstract][Full Text] [Related]
6. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors. Safavi-Sohi R; Maghari S; Raoufi M; Jalali SA; Hajipour MJ; Ghassempour A; Mahmoudi M ACS Appl Mater Interfaces; 2016 Sep; 8(35):22808-18. PubMed ID: 27526263 [TBL] [Abstract][Full Text] [Related]
7. Hepatic Cellular Distribution of Silica Nanoparticles by Surface Energy Modification. Lee AR; Nam K; Lee BJ; Lee SW; Baek SM; Bang JS; Choi SK; Park SJ; Kim TH; Jeong KS; Lee DY; Park JK Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387201 [TBL] [Abstract][Full Text] [Related]
8. Cholera Toxin Subunit B Enabled Multifunctional Glioma-Targeted Drug Delivery. Guan J; Zhang Z; Hu X; Yang Y; Chai Z; Liu X; Liu J; Gao B; Lu W; Qian J; Zhan C Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28841776 [TBL] [Abstract][Full Text] [Related]
9. Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins. Xu J; Lee SS; Seo H; Pang L; Jun Y; Zhang RY; Zhang ZY; Kim P; Lee W; Kron SJ; Yeo Y Small; 2018 Dec; 14(50):e1803601. PubMed ID: 30411856 [TBL] [Abstract][Full Text] [Related]
10. Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo. Zhang ZA; Xin X; Liu C; Liu YH; Duan HX; Qi LL; Zhang YY; Zhao HM; Chen LQ; Jin MJ; Gao ZG; Huang W J Nanobiotechnology; 2021 Dec; 19(1):453. PubMed ID: 34963449 [TBL] [Abstract][Full Text] [Related]
11. Research progress and application opportunities of nanoparticle-protein corona complexes. Huang W; Xiao G; Zhang Y; Min W Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776 [TBL] [Abstract][Full Text] [Related]
12. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853 [TBL] [Abstract][Full Text] [Related]
13. Protein corona: a new approach for nanomedicine design. Nguyen VH; Lee BJ Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536 [TBL] [Abstract][Full Text] [Related]
14. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties. Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014 [TBL] [Abstract][Full Text] [Related]
15. Stealthy nanoparticles protect endothelial barrier from leakiness by resisting the absorption of VE-cadherin. Huang Y; Wang S; Zhang J; Wang H; Zou Q; Wu L Nanoscale; 2021 Aug; 13(29):12577-12586. PubMed ID: 34259298 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-protein complexes mimicking corona formation in ocular environment. Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757 [TBL] [Abstract][Full Text] [Related]
17. Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy. Sharma B; Peetla C; Adjei IM; Labhasetwar V Cancer Lett; 2013 Jul; 334(2):228-36. PubMed ID: 23523612 [TBL] [Abstract][Full Text] [Related]
18. Protein corona modulates interaction of spiky nanoparticles with lipid bilayers. Fleury JB; Werner M; Guével XL; Baulin VA J Colloid Interface Sci; 2021 Dec; 603():550-558. PubMed ID: 34216951 [TBL] [Abstract][Full Text] [Related]
19. Pre-coating cRGD-modified bovine serum albumin enhanced the anti-tumor angiogenesis of siVEGF-loaded chitosan-based nanoparticles by manipulating the protein corona composition. Wu Z; Yuan C; Xia Q; Qu Y; Yang H; Du Q; Xu B Int J Biol Macromol; 2024 May; 267(Pt 2):131546. PubMed ID: 38614172 [TBL] [Abstract][Full Text] [Related]
20. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum. Mirshafiee V; Kim R; Mahmoudi M; Kraft ML Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]